References
- Reyna-Sepúlveda F, Ponce-Escobedo A, Guevara-Charles A, et al. Outcomes and surgical complications in kidney transplantation. Int J Organ Transplant Med. 2017;8(2):78–84.
- de la Rosa-García E, Mondragón-Padilla A, Irigoyen-Camacho ME, et al. Oral lesions in a group of kidney transplant patients. Med Oral Patol Oral Cir Bucal. 2005;10(3):196–204.
- Al-Mohaya MA, Darwazeh AM, Bin-Salih S, et al. Oral lesions in Saudi renal transplant patients. Saudi J Kidney Dis Transpl. 2009;20(1):20–29.
- Mansourian A, Manouchehri A, Shirazian S, et al. Comparison of oral lesion prevalence between renal transplant patients and dialysis patients. J Dent (Tehran). 2013;10(6):487–493.
- Rezvani G, Davarmanesh M, Azar MR, et al. Oral manifestations of allograft recipients before and after renal transplantation. Saudi J Kidney Dis Transpl. 2014;25:278–284.
- Kaswan S, Patil S, Maheshwari S, et al. Prevalence of oral lesions in kidney transplant patients: a single center experience. Saudi J Kidney Dis Transpl. 2015;26:678–683.
- De la Rosa-García E, Mondragón-Padilla A. Oral lesions associated to immunosuppression in kidney transplant patients. Rev Med Inst Mex Seguro Soc. 2014;52(4):442–447.
- Güleç AT, Haberal M. Lip and oral mucosal lesions in 100 renal transplant recipients. J Am Acad Dermatol. 2010;62(1):96–101.
- Sahebjamee M, Shakur Shahabi M, Nikoobakht MR, et al. Oral lesions in kidney transplant patients. Iran J Kidney Dis. 2010;4(3):232–236.
- López-Pintor RM, Hernández G, de Arriba L, et al. Oral candidiasis in patients with renal transplants. Med Oral. 2013;18:e381–387.
- Imko-Walczuk BB, Prędota A, Okuniewska A, et al. Superficial fungal infections in renal transplant recipients. Transplant Proc. 2014;46(8):2738–2742.
- da Silva LC, de Almeida Freitas R, de Andrade MP, Jr, et al. Oral lesions in renal transplant. J Craniofac Surg. 2012;23(3):e214–218.
- Coleman GC, Flaitz CM, Vincent SD. Differential diagnosis of oral soft tissue lesions. Tex Dent J. 2002;119(6):484–488, 490–492, 494–503.
- Liu J, Liu D, Li J, et al. Efficacy and safety of everolimus for maintenance immunosuppression of kidney transplantation: a meta-analysis of randomized controlled trials. PLoS One. 2017;12(1):e0170246.
- Kalogirou EM, Tosios KI, Piperi EP, et al. mTOR inhibitor-associated stomatitis (mIAS) in three patients with cancer treated with everolimus. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(1):e13–19.
- de Oliveira MA, Martins E, Martins F, et al. Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral Oncol. 2011;47(10):998–1003.
- Sonis S, Treister N, Chawla S, et al. Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients. Cancer. 2010;116(1):210–215.
- Weng RR, Foster CE, 3rd, Hsieh LL, et al. Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient. Am J Health Syst Pharm. 2011;68(7):585–588.
- Philipone E, Rockafellow A, Sternberg R, et al. Oral ulcerations as a sequel to tacrolimus and mycophenolate mofetil therapy. Oral Surg Oral Med Oral Oral Oral Radiol. 2014;118(6):e175–178.
- Plana-Pla A, Solé LC, Garcia AB, et al. Mycophenolate mofetil-induced mouth ulcers in a kidney transplant patient: case report and literature review. Nefrologia. 2019;39(1):80–83.
- Peterson DE, O’Shaughnessy JA, Rugo HS, et al. Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice. Cancer Med. 2016;5(8):1897–1907.
- Gupta KL, Ghosh AK, Kochhar R, et al. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols. Am J Gastroenterol. 1994;89(7):1062–1065.
- King PD. Renal transplantation. N Engl J Med. 1994;331:1719–1720.
- Spolidorio LC, Spolidorio DM, Massucato EM, et al. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral Dis. 2006;12(3):309–314.
- López-Pintor RM, Hernández G, de Arriba L, et al. Comparison of oral lesion prevalence in renal transplant patients under immunosuppressive therapy and healthy controls. Oral Dis. 2010;16:89–95.
- Summers SA, Tilakaratne WM, Fortune F, et al. Renal disease and the mouth. Am J Med. 2007;120(7):568–573.
- Netchiporouk E, Tchervenkov J, Paraskevas S, et al. Evaluation of herpes simplex virus infection morbidity and mortality in pancreas and kidney-pancreas transplant recipients. Transplant Proc. 2013;45(9):3343–3347.
- Rojas G, Bravo L, Cordero K, et al. Integrity of the oral tissues in patients with solid-organ transplants. J Transplant. 2012;2012:1.
- Orsal E, Seven B, Keles M, et al. Assessment of salivary gland function in patients after successful kidney transplantation using (99m)Tc-pertechnetate salivary gland scintigraphy. Hell J Nucl Med. 2013;16(2):107–110.
- Khanum N, Mysore-Shivalingu M, Basappa S, et al. Evaluation of changes in salivary composition in renal failure patients before and after hemodialysis. J Clin Exp Dent. 2017;9:e1340–e1345.